VirtualScopics, Inc. To Webcast Annual Meeting Of Shareholders On June 2, 2015; Five Members Of Management To Provide Insight On Operational Excellence And Future Outlook

May 19, 2015, 11:39 ET from VirtualScopics, Inc.

ROCHESTER, N.Y., May 19, 2015 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced it will webcast the 2015 Annual Meeting of Shareholders on Tuesday, June 2, 2015, beginning at 10:00 a.m.  The meeting will be held at the Country Club of Rochester, 2935 East Avenue, Rochester, New York, and is open to all VirtualScopics shareholders.  Information for this year's Annual Meeting, including the company's Annual Report, Form 10-K and Proxy Statement, can be found on the company's website, www.virtualscopics.com

"At last year's Annual Meeting of Shareholders we focused on the science of our business and marketing and business development," said Eric Converse, President and Chief Executive Officer.  "This year, our theme is "Operational Excellence" and in addition to Jim Groff, Chief Financial Officer, and myself, featured presenters will be Ron Way, Vice President of Operations; Mike Barrett, Director of Data Management; and Lianne Cox, Director of Project Management."

The webcast of the Annual Meeting, including featured slide presentations, can be accessed on the company's website at www.virtualscopics.com, under "investors" and "webcasts" or at http://www.investorcalendar.com/IC/CEPage.asp?ID=174030.  A replay of the webcast and slide presentations will be available one hour after the conclusion of the Annual Meeting of Shareholders and will be archived on the company's website.

About VirtualScopics, Inc. VirtualScopics, Inc. (NASDAQ: VSCP) is a leading provider of clinical trial imaging solutions to accelerate drug and medical device development.  For risk-averse, time-constrained Clinical Trial Study Teams, Medical Directors and Imaging Scientists who require quality imaging data delivered on-time, within budget and on a consistent basis, VirtualScopics' clinical trial imaging solutions are an inspired true exception to commonly-accepted services provided by other clinical trial imaging providers.  Because of the scientific and operational flexibility and responsiveness available, VirtualScopics' clinical trial imaging solutions deliver special performance advantages compared to other image service providers that offer common, every day clinical trial imaging services.  For more information on VirtualScopics, Inc., please visit www.virtualscopics.com.

Forward-looking Statements The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of the Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby.  These forward-looking statements include, but are not limited to, statements regarding the expected benefits of the company's investment in infrastructure, sales and marketing efforts, the increase in backlog, awards and bookings and the performance of existing projects and/or statements preceded by, followed by or that include the words "believes", "could", "expects", "anticipates", "estimates", "intends", "plans", "projects", "seeks", or similar expressions.  Forward-looking statements deal with the company's current plans, intentions, beliefs and expectations.  Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements.  Many of these risks and uncertainties are discussed in the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014 filed with the Securities and Exchange Commission (the "SEC"), and in any subsequent reports filed with the SEC, all of which are available at the SEC's website at www.sec.gov.  These include without limitation: the risk of cancellation or delay of customer contracts or that contract awards do not turn into signed contracts.  Other risks include the company's dependence on its largest customers and risk of contract performance, protection of our intellectual property and the risks of infringement on the intellectual property rights of others.  All forward-looking statements speak only as of the date of this press release and the company undertakes no obligation to update such forward-looking statements.

For More Information, Contact: Donna N. Stein, APR, Fellow PRSA Managing Partner Donna Stein & Partners Phone:  315-361-4672 Email:  dstein1@twcny.rr.com

SOURCE VirtualScopics, Inc.



RELATED LINKS

http://www.virtualscopics.com